Exploring new treatments for muscular dystrophy
MDSRC for Next Directions in Muscular Dystrophy Research
This study is exploring new gene therapies for Limb Girdle Muscular Dystrophy 2I to help improve muscle function and slow down the disease, with the hope that patients will experience better treatments and an improved quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10992522 on NIH RePORTER |
What this research studies
This research focuses on developing innovative gene therapies for muscular dystrophy, particularly targeting Limb Girdle Muscular Dystrophy 2I. The team at Nationwide Children's Hospital is investigating the use of advanced AAV vectors to enhance muscle function and prevent disease progression. They aim to identify new biomarkers and improve gene therapy effectiveness while minimizing immune responses. Patients may benefit from cutting-edge treatments that could significantly improve their quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Limb Girdle Muscular Dystrophy 2I or other forms of muscular dystrophy.
Not a fit: Patients with muscular dystrophy types not targeted by this research may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking therapies that restore muscle function and slow disease progression in muscular dystrophy patients.
How similar studies have performed: Previous research has shown promise in gene therapy approaches for muscular dystrophy, indicating potential for success in this novel investigation.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Flanigan, Kevin M — Research Inst Nationwide Children's Hosp
- Study coordinator: Flanigan, Kevin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.